IBM's 25% weekly drop erased $40 billion in market value after consulting revenue grew just 1%, half the expected rate. The selloff drew upgrade calls from value funds, but the bear case centers on a slowing IT services cycle that could persist.
Alpha Score of 47 reflects weak overall profile with weak momentum, moderate value, weak quality, moderate sentiment.
IBM shares dropped 25% this week, the steepest single-week decline in over a decade. The selloff wiped roughly $40 billion in market value and followed an earnings release that showed consulting revenue grew just 1% in the quarter – half the 4% Wall Street expected.
Chief Financial Officer James Kavanaugh told analysts on the call that enterprise clients, especially in Europe and parts of Asia, are “taking longer to commit to large transformation projects.” That dynamic pinched bookings in the consulting unit, which accounts for about a third of total revenue.
AlphaScala's model tags IBM with an Alpha Score of 37 out of 100, labeled Mixed. The low valuation – around 14 times forward earnings, near a five-year trough – pulls one way. The deteriorating near-term revenue trajectory pulls the other. The Technology sector score gets dragged down by the consulting slowdown, though the mainframe and Red Hat units still post steady numbers.
Value buyers have started circling. At least three analysts upgraded the stock to Buy this week, arguing the drop overstates the risk from a cyclical IT services pullback. The counterargument centers on the consulting unit's exposure to a slowing spending cycle that could stretch several more quarters.
IBM maintained its full-year revenue growth guidance of 3% to 5% in constant currency. That target now depends heavily on a second-half rebound in consulting demand. The next quarterly report is due in October.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.